본문으로 건너뛰기
← 뒤로

Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report.

증례보고 1/5 보강
Frontiers in oncology 2026 Vol.16() p. 1721390
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
external beam radiation therapy to the prostate, receiving a total dose of 3000 cGy delivered in 15 fractions
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Follow-up abdominal and urinary tract ultrasound examinations at 1week, 1month, and 4months post-radiotherapy showed marked tumor regression with no signs of recurrence. This report aims to share the treatment experience of this case, hoping to provide insights for clinicians.

Gao X, Wang X, Wang X, Cai H

📝 환자 설명용 한 줄

This report describes a clinically rare case of early-stage primary extranodal marginal zone B-cell lymphoma of the prostate.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Gao X, Wang X, et al. (2026). Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report.. Frontiers in oncology, 16, 1721390. https://doi.org/10.3389/fonc.2026.1721390
MLA Gao X, et al.. "Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report.." Frontiers in oncology, vol. 16, 2026, pp. 1721390.
PMID 41847690

Abstract

This report describes a clinically rare case of early-stage primary extranodal marginal zone B-cell lymphoma of the prostate. A 73-year-old male presented with urinary hesitancy. Physical examination revealed mild prostatic enlargement. Prostate biopsy, immunohistochemistry, and genetic testing strongly suggested mucosa-associated lymphoid tissue (MALT) lymphoma. Bone marrow aspiration indicated no bone marrow involvement. Positron Emission Tomography-Computed Tomography (PET-CT) and Emission Computed Tomography (ECT) scans showed no evidence of involvement in other sites. Ultimately, the patient was definitively diagnosed with primary prostatic MALT lymphoma, Ann Arbor stage IE. He underwent external beam radiation therapy to the prostate, receiving a total dose of 3000 cGy delivered in 15 fractions. During radiotherapy, the patient experienced no significant adverse reactions. Following treatment, urinary obstruction symptoms markedly improved. Follow-up abdominal and urinary tract ultrasound examinations at 1week, 1month, and 4months post-radiotherapy showed marked tumor regression with no signs of recurrence. This report aims to share the treatment experience of this case, hoping to provide insights for clinicians.

같은 제1저자의 인용 많은 논문 (5)